Skip to content

Metabolic Response to the Acute Consumption of Fiber-enriched Pasta

Effects of the Consumption of Fiber-enriched Pasta on Glucose and Lipid Metabolism and Satiety

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02842606
Acronym
PROPASTA
Enrollment
13
Registered
2016-07-25
Start date
2015-03-31
Completion date
2016-07-31
Last updated
2017-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Volunteers

Brief summary

Cardio-metabolic diseases are a leading cause of mortality worldwide. Over the years, therefore, there have been considerable efforts to identify strategies for prevention and management of risk factors. The diet, with its pleiotropic effects, is one of the most effective approaches to reduce the cardio-metabolic risk. In this context, the dietary fibers have been extensively studied and the available evidence supports the beneficial effects of its consumption. However, worldwide the average fiber consumption is still less than the recommended daily dose. For this reason, the availability of functional foods, such as additional sources of fiber in the diet, may facilitate the attainment of fiber recommended.

Interventions

OTHERTest meal

The two test meals are designed to have the same energy and macronutrient composition. They differ only in the carbohydrate source: fiber-enriched pasta or control pasta. Blood samples are taken at fasting and every 30 minutes over 4 hours. Fasting and postprandial intestinal fermentation is evaluated by breath test.

Sponsors

Federico II University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
30 Years to 70 Years
Healthy volunteers
Yes

Inclusion criteria

* BMI 18-29 kg / m2 * Good Health status

Exclusion criteria

* Diabetes * Cardiovascular events (IMA or stroke) severe heart disease * Kidney or liver failure * Anemia and any other chronic disease

Design outcomes

Primary

MeasureTime frameDescription
Glucose and lipid response4 hoursEvaluated by enzymatic colorimetric methods

Secondary

MeasureTime frameDescription
Insulin response4 hoursEvaluated by ELISA
Hormone response (GLP-1, GIP, PYY and Ghrelin)4 hoursEvaluated by ELISA
Energy intake in the subsequent meal.4 hoursEvaluated by food record

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026